Plus Therapeutics (PSTV) Soars 40% as Firm Seals Partnership with United Healthcare
Under the partnership, Plus Therapeutics Inc.
Plus Therapeutics Inc. (PSTV)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Altium Capital Jacob Gottlieb | 918,914 | $628,262 | 100% | |
| 2. | Scientech Research Le Duan | 146,654 | $100,267 | 0.03% | |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.51 | 20,000 | $10,200.00 | 68,138 | 2025-11-04 | Filing | |
| $0.49 | 110,000 | $53,779.00 | 139,327 | 2025-08-22 | Filing | |
| $1.50 | 4,000 | $5,996.00 | 15,188 | 2024-09-13 | Filing | |
| $1.35 | 6,285 | $8,511.78 | 11,188 | 2024-09-12 | Filing | |
| $1.35 | 12,500 | $16,875.00 | 48,921 | 2024-09-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.96 | 2,068 | $4,052.66 | 170 | 2023-11-20 | Filing | |
| $0.31 | 1,500 | $472.05 | 8,500 | 2022-12-30 | Filing | |
| $0.34 | 473,831 | $161,007.77 | 4,543,086 | 2018-02-14 | Filing | |
| $0.31 | 101,710 | $31,652.15 | 5,016,917 | 2018-02-13 | Filing | |
| $0.31 | 185,272 | $58,323.63 | 5,118,627 | 2018-02-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,446,827 | $989,630 | 0% | |
| 2. | 813,250 | $556,018 | 0% | |
| 3. | 623,874 | $426,730 | 0% | |
| 4. | 469,389 | $320,921 | 0% | |
| 5. | 341,893 | $233,752 | 0% |
News See All
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics' Fourth Quarter and Full Year 2024 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics Third Quarter 2024 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus’ Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics' First Quarter 2024 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript
Plus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.7, expectations were $-0.78.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Third Quarter 2023 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Second Quarter 2023 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Fourth Quarter and Full Year 2022 Results Conference Call.
Hedge Fund Resource Center Billionaire Hedge Funds
